Toward a GEP-based PET in myeloma
2017; Elsevier BV; Volume: 130; Issue: 1 Linguagem: Inglês
10.1182/blood-2017-05-781278
ISSN1528-0020
Autores Tópico(s)Peptidase Inhibition and Analysis
ResumoIn this issue of Blood , Rasche et al provide the first evidence of the biological basis underlying the occurrence of false-negative scans with use of 18 F-fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) in newly diagnosed transplant-eligible multiple myeloma (MM) patients. 1
Referência(s)